Drug-Coated Balloons for Acute Myocardial Infarction: A Metaanalysis of Randomized Clinical Trials

Figure 2

Summary plots for the clinical endpoint. Risk ratios of major adverse cardiac events (a), myocardial infarction (b), all-cause death (e), cardiovascular mortality (f), stent thrombosis (g), and target lesion revascularization (h); subgroup analysis for major adverse cardiac events (c) and myocardial infarction (d) according to indication. The relative size of the data markers indicates weight of sample size from each study. DCB: drug-coated balloon; DES: drug-eluting stent; BMS: bare-metal stent.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)